Apeiron Capital Investment Corp. (APNC) to Combine with GIO World Health in $250M Deal
Apeiron (OTC:APNC) has entered into a definitive agreement to combine with biotech firm GIO World Health at a pre-money enterprise value of $250 million. The San Diego-based company is developing stem cell-based therapies in the US and Europe with an eye to applying these to anti-aging products. The deal is expected to be completed inRead More
To access this post, you must purchase 1 - User: Monthly Plan.